Chief executive has been at the helm of the institute since it was founded in April 1999
NICE has today (23 August 2019) announced its intention to work with GW Pharma to address the issues highlighted by its independent appraisal committee in its evaluation of cannabidiol for treating 2 types of severe treatment-resistant epilepsy.
It's estimated that 86 people would be eligible for treatment with voretigene neparvovec in England
Providing support after a suspected suicide can reduce this risk, especially when tailored to the person’s needs.
Recruitment for the 2020 intake is open until 28 October 2019
It is estimated that in the UK there are around 30 to 50 children living with the condition
Heidi Livingstone, senior public involvement adviser within NICE's Public Involvement Programme, reflects on the partnership with CMAC
Another new life-extending treatment for some people with lung cancer is to be made available on the Cancer Drugs Fund (CDF) following its approval by NICE in draft guidance published today (8 August 2019).
NICE has today (8 August 2019) published its draft recommendations on the use of cannabis-based medicinal products following a comprehensive evaluation of their clinical and cost-effectiveness.
NICE has today (7 August 2019) published draft guidance recommending neratinib as an additional treatment for some people with early hormone-receptor-positive, human epidermal growth factor receptor 2 (HER2)-positive breast cancer.
Aspirin taken daily for 2 years or more could reduce the risk of colorectal cancer in people with Lynch syndrome (LS), says NICE in new draft updated guidance.
NICE has published new draft guidance which aims to improve the wellbeing of adults who provide unpaid care for people over 16 years old.
Kathryn Mason, Head of Hospital Inspection (mental health), discusses the work CQC is undertaking to improve the quality and safety of mental health services
Olaparib, a medicine that has previously been used at a later stage in the treatment of advanced ovarian cancer, has now been approved by NICE as a first-line maintenance treatment.
Recommendation ID NG77/1 Question Toric lenses for astigmatism:- What is the cost effectiveness of toric lenses compared with on-axis or
Recommendation ID NG78/3 Question Monitoring pulmonary disease:- Is lung clearance index a useful and cost-effective tool for the routine
Recommendation ID NG77/3 Question Indicators and thresholds for referral for cataract surgery:- What is the association between preoperative
Recommendation ID IPG592 Question Further research on high-intensity focused ultrasound for symptomatic breast fibroadenoma should include
Recommendation ID NG78/2 Question Airway clearance techniques:- How effective are daily airway clearance techniques in maintaining lung
Recommendation ID DG29/2 Question NICE recommended that data on the effect of BCM – Body Composition Monitor-guided monitoring on health-related
Recommendation ID NG69/2 Question Duration and intensity of psychological treatment:- What is the effectiveness of treating eating disorders
Recommendation ID DG28/2 Question Data collection and analysis are recommended to monitor the effect on endoscopy and histopathology services
Recommendation ID NG68/1 Question What measures would make up an effective, standardised approach to evaluation of condom distribution schemes
Recommendation ID NG68/1 Question What behaviour change techniques are most effective as part of a condom distribution scheme?:- What combinations
Recommendation ID NG68/2 Question How can the effectiveness and cost effectiveness of condom schemes in the UK be improved for people at
Recommendation ID NG68/4 Question How can digital technologies be used to increase access to, and uptake of, condom schemes?:- Can digital
Recommendation ID NG68/5 Question Can GP practices deliver effective and cost effective condom schemes to reduce STIs?: -Can condom schemes
Recommendation ID IPG602/1 Question NICE encourages further research into total artificial heart implantation as a bridge to transplantation
Recommendation ID IPG599/1 Question Further research on the safety of transvaginal mesh repair of anterior or posterior vaginal wall prolapse should
Recommendation ID NG81/2 Question Treatment for people with an IOP of 22 or 23 mmHg:- What is the clinical and cost effectiveness of treating
Recommendation ID NG80/6 Question Starting asthma treatment:- In adults, young people and children with asthma who have not been treated
Recommendation ID NG80/7 Question Second-line maintenance therapy in children and young people (under 16):- Is maintenance therapy more
Recommendation ID NG81/1 Question Risk tools to identify risk of developing COAG and risk of sight loss:- What is the predictive value of
Recommendation ID NG81/5 Question Referral filtering:- What is the effectiveness and cost effectiveness of the different models for glaucoma
Recommendation ID NG81/4 Question Optical coherence tomography for glaucoma:- What is the effectiveness and cost effectiveness of optical
Recommendation ID NG80/4 Question Monitoring inhaler technique:- What is the current frequency and the current method being used to check
Recommendation ID NG80/5 Question Monitoring asthma control using tele-healthcare:- What is the long-term (more than 12 months) clinical
Recommendation ID NG80/3 Question Monitoring adherence to treatment:- What is the clinical and cost effectiveness of using electronic alert
Recommendation ID NG80/10 Question Improving adherence to asthma medication:- What are the most clinically and cost-effective strategies
Recommendation ID IPG595/1 Question Further research on the safety and efficacy of total distal radioulnar joint replacement for symptomatic
Recommendation ID DG31/3 Question Further research is recommended to assess the diagnostic accuracy of the tests included in this assessment
Recommendation ID NG76/13 Question Effective interventions for parents or carers with substance misuse problems:- What interventions, including
Recommendation ID NG76/8 Question Effective interventions for children and young people who have experienced online-facilitated abuse, including
Recommendation ID NG76/9 Question Effective interventions for addressing child abuse and neglect in the UK:- What interventions, approaches
Recommendation ID NG76/4 Question Early help home visiting:- What are the components of effective home visiting programmes for preventing
Recommendation ID NG74/2 Question Team composition for home-based intermediate care:- How effective and cost effective are different approaches
Recommendation ID NG75/5 Question Support needs of parents:- What are the experiences and concerns of parents of children with faltering
Recommendation ID NG74/8 Question Support for black and minority ethnic groups:- How effective and cost effective are different approaches
Recommendation ID NG74/5 Question Reablement:- How effective and cost effective are repeated periods of reablement, and reablement that
Recommendation ID NG73/1 Question Pain management programmes:- Are pain management programmes a clinically and cost-effective intervention